ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,751.41
-0.22%
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs Yen
153.055
0.00%
Brent Oil
82.765
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. RespireRx Pharmaceuticals Inc (PK) (RSPI)

  7. RespireRx Pharmaceuticals Inc (PK) (RSPI) ニュース

RSPI

RespireRx Pharmaceuticals (PK) (RSPI)

RespireRx Pharmaceuticals Inc (PK)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:RSPI
日付受信時刻ニュースソース見出しコード企業名
2024/02/0222 : 30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2024/01/2222 : 45Edgar (US Regulatory)Form 8-K - Current reportUSOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2023/12/1122 : 45Edgar (US Regulatory)Form 8-K - Current reportUSOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2023/11/1806 : 06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2023/11/1506 : 05Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2023/10/1222 : 00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2023/10/0221 : 45Edgar (US Regulatory)Form 8-K - Current reportUSOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2023/08/2205 : 05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2023/08/1505 : 15Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2023/08/0921 : 52Edgar (US Regulatory)Form 8-K - Current reportUSOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2023/06/1405 : 11Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2023/05/2421 : 46Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2023/05/2305 : 17Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2023/05/1605 : 08Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2023/05/0605 : 06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2023/04/1321 : 31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2023/03/2821 : 56Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2023/03/0122 : 52Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2023/02/0122 : 46Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2023/01/2322 : 46Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2023/01/1223 : 01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2022/11/1723 : 01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2022/11/1023 : 02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2022/09/1405 : 07Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2022/08/2305 : 06Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2022/08/1605 : 14Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2022/08/0405 : 06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2022/05/1622 : 16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2022/04/1603 : 17Edgar (US Regulatory)Annual Report (10-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2022/04/0422 : 22Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
 Showing the most relevant articles for your search:USOTC:RSPI

最近閲覧した銘柄

NYSE
NKE
Nike
NYSE
CVX
Chevron
COIN
ETHUSD
Ethereum
FX
USDJPY
US Dollar vs Yen
NASDAQ
AAPL
Apple
NASDAQ
TSLA
Tesla
NASDAQ
AMZN
Amazon.com
CCOM
US100
US Tech 100
AMEX
XLV
Health Care Select Sector
USOTC
ADDYY
Adidas (QX)
SPI
SP500
S&P 500
CCOM
SILVER
SILVER
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
AXP
American Express
FX
USDEUR
US Dollar vs Euro
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有